Complex drug formulations, stringent regulatory standards, and a tough capital landscape are creating pressure for drug developers as they approach clinical trials. ...

When developing a tablet, three widely used technologies are often considered to produce solid dosage forms: direct compression, wet granulation and dry granulation....

Global warming is a critical consequence of using fossil feedstocks to produce plastics and energy. In addition, the reserves of fossil feedstocks are going to run o...

The rise of advanced therapy medicinal products (ATMPs) marks a new era in medicine, offering unprecedented possibilities for treating previously intractable disease...

The development of oil-based long-acting injectable formulations (LAIF) involves creating a formulation where an active drug is dissolved or suspended in an oil-base...

It’s August of 1970 and you have discovered a mysterious rash on your arm after applying a copious amount of your favourite moisturising cream. Being that this is yo...

Beneath the surface of the digital transformation revolution lies a growing concern: digital transformation fatigue. This phenomenon, particularly in highly regulate...

On average, a clinical trial generates up to three million data points. These data points provide extensive insights into the health status of study participants – t...

Since 2022, the FDA has issued more than 600 warning letters for violations of GxP requirements. Regardless of the origin – poor documentation, incorrect data collec...

The pharmaceutical industry is at a pivotal moment in its evolution, as artificial intelligence (AI) and machine learning (ML) technologies reshape supply chain dyna...